Prior COVID-19 vaccination did not stop the immune system from mounting a protective response to the delta and omicron ...

A University of Arizona-led study published in Nature Immunology has found that prior covid-19 vaccination did not block the ...

Creative Biolabs recently updated its antibody chip platform, expanding product arrays for phosphorylation signaling and ...

A study appearing in Nature investigated the role of astrocytes, an abundant cell type in the brain, in regulating an immune ...

Groundbreaking study reveals TR1 cells' crucial role in immune response to malaria, paving way for new vaccines and drugs.

The antibody PLT012 targets the fat transporter CD36 to restore immune responses in tumors, offering a new and promising ...

Prior COVID-19 vaccination did not stop the immune system from mounting a protective response to the Delta and Omicron strains, though new mutation-specific antibody production dipped slightly, ...

Scientists have created a new type of super-strong antibody that could significantly enhance cancer immunotherapy. In an ...

“The FDA’s decision to grant Fast Track designation for TEV-53408, an investigational anti-IL-15 antibody therapy, reflects the promising nature of the treatment and the urgent unmet need of people ...

We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for ...

One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects.